To review the pathogenesis of pulmonary vascular complications of liver disease, we discuss their clinical implications, and therapeutic considerations, with emphasis on potential reversibility of the hepatopulmonary syndrome after liver transplantation. In this review, we also discuss the role of imaging in pulmonary vascular complications associated with liver disease
Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two major pulmonary v...
Background: Both hepatopulmonary syndrome and portopulmonary hypertension are associated with chroni...
Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are two frequent pulmonary com...
The hepatopulmonary syndrome is characterized as the triad of liver disease, pulmonary gas exchange ...
Liver disease, cirrhosis and portal hypertension can be complicated by pulmonary vascular disease, w...
Lung complications may occur as a result of hepatic disease from any cause and represent a highly he...
Liver disease affects the lungs. The most com-mon pulmonary consequence of liver disease is al-tered...
Hepatopulmonary syndrome (HPS) is a pulmonary complication of liver disease characterized by arteria...
Pulmonary disease in liver cirrhosis and portal hypertension (PH) constitutes a challenging clinical...
Hepatopulmonary syndrome (HPS) is a pulmonary complication observed in patients with chronic liver d...
Hepatopulmonary syndrome (HPS) is characterized by abnormalities in blood oxygenation caused by the ...
AbstractIntroductionEnd-stage liver disease and its complications are a leading cause of death among...
Hepatopulmonary syndrome (HPS) is a clinical threesome composed of liver disease, intrapulmonary vas...
Rationale: Pulmonary vascular complications of liver disease are poorly understood but contribute si...
The liver and the heart are closely related organs connected by large vessels. Thus, the heart may b...
Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two major pulmonary v...
Background: Both hepatopulmonary syndrome and portopulmonary hypertension are associated with chroni...
Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are two frequent pulmonary com...
The hepatopulmonary syndrome is characterized as the triad of liver disease, pulmonary gas exchange ...
Liver disease, cirrhosis and portal hypertension can be complicated by pulmonary vascular disease, w...
Lung complications may occur as a result of hepatic disease from any cause and represent a highly he...
Liver disease affects the lungs. The most com-mon pulmonary consequence of liver disease is al-tered...
Hepatopulmonary syndrome (HPS) is a pulmonary complication of liver disease characterized by arteria...
Pulmonary disease in liver cirrhosis and portal hypertension (PH) constitutes a challenging clinical...
Hepatopulmonary syndrome (HPS) is a pulmonary complication observed in patients with chronic liver d...
Hepatopulmonary syndrome (HPS) is characterized by abnormalities in blood oxygenation caused by the ...
AbstractIntroductionEnd-stage liver disease and its complications are a leading cause of death among...
Hepatopulmonary syndrome (HPS) is a clinical threesome composed of liver disease, intrapulmonary vas...
Rationale: Pulmonary vascular complications of liver disease are poorly understood but contribute si...
The liver and the heart are closely related organs connected by large vessels. Thus, the heart may b...
Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two major pulmonary v...
Background: Both hepatopulmonary syndrome and portopulmonary hypertension are associated with chroni...
Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are two frequent pulmonary com...
Add to ORKG